Patient Leaflet Updated 20-Apr-2023 | Martindale Pharma, an Ethypharm Group Company
Dexmedetomidine 4 micrograms/ml solution for infusion
Dexmedetomidine 4 micrograms/ml solution for infusion
dexmedetomidine
1. What is Dexmedetomidine and what it is used for
2. What you need to know before you are given Dexmedetomidine
3. How to use Dexmedetomidine
4. Possible side effects
5. How to store Dexmedetomidine
6. Contents of the pack and other information
Dexmedetomidine contains an active substance called dexmedetomidine which belongs to a medicine group called sedatives. It is used to provide sedation (a state of calm, drowsiness or sleep) for adult patients in hospital intensive care settings or awake sedation during different diagnostic or surgical procedures.
Before you have this medicine, tell your doctor or nurse if any of the following apply as Dexmedetomidine should be used cautiously:
This medicine may cause large amount of urine and excessive thirst, contact a doctor if these side effects occur. See section 4 for more information.
An increased risk of mortality has been observed in patients 65 years of age and younger when using this medication, especially in patients admitted to the intensive care unit for reasons other than postoperative care, with more severe illness on admission to the care unit intensive and with a younger age. The doctor will decide if this medicine is still suitable for you. The doctor will consider the benefits and risks of this medicine for you, in comparison with treatment with other sedatives.
Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines.
The following medicines may enhance the effect of Dexmedetomidine
If you are using medicines which lower your blood pressure and heart rate, co-administration with Dexmedetomidine may enhance this effect. Dexmedetomidine should not be used with medicines that cause temporary paralysis.
If you are pregnant or breast-feeding, think that you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
Dexmedetomidine should not be used during pregnancy or breast-feeding unless clearly necessary.
Dexmedetomidine has major impact on the ability to drive and use machines.
After you have been given Dexmedetomidine you must not drive, operate machinery, or work in dangerous situations until the effects are completely gone. Ask your doctor when you can start doing these activities again and when you can go back to this kind of work.
Dexmedetomidine contains 5.5 g glucose per 100 ml. This should be taken into account in patients with diabetes mellitus.
Hospital intensive care
Dexmedetomidine is administered to you by a doctor or nurse in hospital intensive care.
Your doctor will decide on a suitable dose for you.
Procedural sedation/awake sedation
Dexmedetomidine is administered to you by a doctor or nurse prior to and/or during diagnostic or surgical procedures requiring sedation, i.e. procedural/awake sedation.
Your doctor will decide on a suitable dose for you. The amount of Dexmedetomidine depends on your age, size, general condition of health, the level of sedation needed and how you respond to the medicine. Your doctor may change your dose if needed and will monitor your heart and blood pressure during the treatment.
Dexmedetomidine is given to you as an infusion (drip) into your veins.
If you are given too Dexmedetomidine, your blood pressure may go up or down, your heartbeat may slow down, you may breathe more slowly and you may feel more drowsy. Your doctor will know how to treat you based on your condition.
If you have any further questions on the use of this medicine, ask your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Not known (frequency cannot be estimated from the available data)
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicinal product does not require any special storage conditions,
Do not use this medicine after the expiry date which is stated on the bag. The expiry date refers to the last day of that month.
Your doctor, nurse or pharmacist knows how to store Dexmedetomidine properly (see section 6).
After first opening, Dexmedetomidine should preferably be used immediately.
Do not throw away any medicines via wastewater.
The active substance Dexmedetomidine is dexmedetomidine. Each ml contains dexmedetomidine hydrochloride equivalent to 4 micrograms dexmedetomidine.
The other ingredients are: glucose monohydrate and water for injection.
Dexmedetomidine is supplied as a solution in a clear, colorless bag. One bag contains 100 ml solution.
Dexmedetomidine is supplied as
Each Polypropylene bag contains one non PVC point for filling and closure of the bag port and one non PVC administration port.
Pack sizes:
Polypropylene bag: 1 x 100 ml, 4 x 100 ml
Not all pack sizes may be marketed.
Manufacturer:
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder
This leaflet was last revised in April 2023
Jupiter House, Mercury Park, Wooburn Green, High Wycombe, Buckinghamshire, HP10 0HH, UK
+44 (0) 1277 266 600